The global vaccines market is expected to register high growth in the forecoming years. Major factors driving growth of the global vaccines markets are ageing population, rise in prevalence of infections, growing population. In addition, increasing popularity of vaccines amongst medical practitioners, increasing diseases such as influenza, malaria, pneumonia, measles, meningococcal meningitis, dengue, HIV, hepatitis, and diphtheria, increasing healthcare spending are factors driving growth of the global vaccines market.

The global vaccines market report has been segmented on the basis of type, diseases, route of administration, and region.

On the basis of type, the global vaccines market has been segmented into conjugate vaccines, inactivated vaccines, live attenuated vaccines, toxoid vaccines, recombinant vaccines, and other vaccines including polysaccharide vaccines, etc. The conjugate vaccine is expected to dominate the global vaccine market during the forecasted years.

On the basis of disease, the global vaccines market has been segmented into pneumococcal disease, influenza, human papilloma virus, meningococcal disease, rotavirus, varicella, diphtheria, pertussis, and tetanus (DPT), polio, hepatitis, measles, mumps, and rubella (MMR), and other indications including pneumococcal, typhoid fever, etc.

Request for the Sample Report Here:

On the basis of route of administration, the global Vaccines market has been segmented into intramuscular, subcutaneous, intradermal, and oral. On the basis of region, the global vaccines markets segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

In 2018, North America vaccines market is expected to account for major share in the global market in terms of revenue, and is expected to maintain its dominance over the forecast period, due to new vaccine launches by pharmaceutical companies, rising per capita income, increasing awareness regarding healthcare in this region. However, Asia Pacific vaccines market is projected to register highest CAGR in the next five years owing to rising incidence of diseases such TB, cute respiratory syndrome (SARS), influenza A (H5N1) virus (avian flu), and chikungunya etc. in this region

Key players operating in the global vaccines market include GlaxoSmithKline plc, Pfizer, Inc., Merck & Co., Inc., Sanofi Pasteur SA, CSL Limited, Emergent BioSolutions, Inc., Johnson & Johnson, MedImmune, LLC, Astellas Pharma Inc., and Daiichi Sankyo Company, Limited.

Leave a Reply

Your email address will not be published. Required fields are marked *

%d bloggers like this: